These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2154030

  • 21. [Value and relevance of metabolic function tests in the diagnosis of primary hyperparathyroidism (author's transl)].
    Schweigart U, Henderkott U, Paterek K, Hartung R, Zilker T, Bottermann P.
    Med Klin; 1976 Feb 13; 71(7):281-5. PubMed ID: 176561
    [Abstract] [Full Text] [Related]

  • 22. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ.
    Scand J Urol Nephrol; 2006 Feb 13; 40(1):35-44. PubMed ID: 16452054
    [Abstract] [Full Text] [Related]

  • 23. Dynamic investigation for evaluation of calcium metabolism and parathyroid function.
    Cioppi F, Falchetti A, Masi L, Brandi ML.
    J Endocrinol Invest; 2003 Feb 13; 26(7 Suppl):83-91. PubMed ID: 14604070
    [Abstract] [Full Text] [Related]

  • 24. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
    Kaplan EL, Fang VS, Sugimoto J, Fredland A.
    Surgery; 1982 Nov 13; 92(5):822-6. PubMed ID: 6291182
    [Abstract] [Full Text] [Related]

  • 25. Renal calcium conservation in recurrent stone-formers with idiopathic hypercalciuria.
    Goulding A, Hocken AG.
    N Z Med J; 1985 Feb 13; 98(772):50-2. PubMed ID: 2983270
    [Abstract] [Full Text] [Related]

  • 26. Urinary cyclic 3',5'-adenosine monophosphate (cAMP): an index of the action of parathyroid hormone on the kidney.
    Marx SJ, Spiegel AM, Brown EM, Downs RW, Attie MF, Stock JL, Levine MA, Aurbach GD.
    Prog Biochem Pharmacol; 1980 Feb 13; 17():182-9. PubMed ID: 6259655
    [Abstract] [Full Text] [Related]

  • 27. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH, Coe FL, Evan AP, Worcester EM.
    BJU Int; 2009 Mar 13; 103(5):670-8. PubMed ID: 18793297
    [Abstract] [Full Text] [Related]

  • 28. Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers.
    Schwietert HR, Groen EW, Sollie FA, Jonkman JH.
    Clin Pharmacol Ther; 1997 Mar 13; 61(3):360-76. PubMed ID: 9084461
    [Abstract] [Full Text] [Related]

  • 29. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S.
    J Med Assoc Thai; 2007 Apr 13; 90(4):688-98. PubMed ID: 17487123
    [Abstract] [Full Text] [Related]

  • 30. Separation of pseudohypoparathyroidism into types I and II using only basal nephrogenous cAMP determinations.
    Singhellakis P, Pappas A, Nicolou CH, Ikkos D.
    Endocrinologie; 1991 Apr 13; 29(1-2):67-71. PubMed ID: 1666440
    [Abstract] [Full Text] [Related]

  • 31. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S, Dopsaj V, Jovicić S, Milenković D, Jovanović D, Nesić V.
    Med Pregl; 2007 Apr 13; 60 Suppl 2():117-20. PubMed ID: 18928175
    [Abstract] [Full Text] [Related]

  • 32. [Cyclic AMP levels in plasma and urine as an index of parathyroid function (author's transl)].
    Campino C, Pumarino H, Connelly C, Generini G.
    Rev Med Chil; 1979 Oct 13; 107(10):897-905. PubMed ID: 233041
    [No Abstract] [Full Text] [Related]

  • 33. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK, Maloney ME, Mathias BJ, Pietrow PK, Preminger GM.
    BJU Int; 2006 May 13; 97(5):1053-6. PubMed ID: 16643491
    [Abstract] [Full Text] [Related]

  • 34. Serum ionized calcium, nephrogenous and total urinary cyclic AMP and urinary phosphate in normal subjects.
    Thode J, Holmegaard SN, Siggaard-Andersen O.
    Scand J Clin Lab Invest; 1984 Apr 13; 44(2):111-8. PubMed ID: 6326252
    [Abstract] [Full Text] [Related]

  • 35. Nephrogenous cyclic AMP as a parathyroid function test.
    Broadus AE.
    Nephron; 1979 Apr 13; 23(2-3):136-41. PubMed ID: 220548
    [Abstract] [Full Text] [Related]

  • 36. A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.
    Kruse K, Kracht U.
    Eur J Pediatr; 1987 Jul 13; 146(4):373-7. PubMed ID: 2820733
    [Abstract] [Full Text] [Related]

  • 37. An enzyme-linked immunosorbent assay (ELISA) for adenosine 3',5'-cyclic monophosphate (cAMP) in human plasma and urine using monoclonal antibody.
    Tsugawa M, Iida S, Fujii H, Moriwaki K, Tarui S, Sugi M, Yamane R, Fujimoto M.
    J Immunoassay; 1990 Jul 13; 11(1):49-61. PubMed ID: 2159028
    [Abstract] [Full Text] [Related]

  • 38. A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects.
    McElduff A, Lissner D, Wilkinson M, Cornish C, Posen S.
    Calcif Tissue Int; 1987 Nov 13; 41(5):267-73. PubMed ID: 2825934
    [Abstract] [Full Text] [Related]

  • 39. Urinary excretion of cyclic AMP in hyperparathyroidism.
    Wålinder O, Ljunghall S, Wibell L.
    Scand J Urol Nephrol; 1978 Nov 13; 12(1):67-71. PubMed ID: 204993
    [Abstract] [Full Text] [Related]

  • 40. [The comprehensive examination of patients with recurrent calcium nephrolithiasis].
    Ivanov II, Tsvetkov MTs, Ormanov ID, Mladenov DD, Drenski OG, Gruev IS, Kumanov KhN.
    Urol Nefrol (Mosk); 1991 Nov 13; (1):13-8. PubMed ID: 1858197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.